Medication info
Hanol Glimepiride Tablets

Hanol Glimepiride Tablets

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Hanol Bio Pharma Co., Ltd.
Appearance
Green rectangular tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200300296 · Notified 2003.09.09 · Insurance code 655602270

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses greater than 4 mg, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the required dose of this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate caution is required.

Ingredients

Manufacturer
Hanol Bio Pharma Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be taken alone while following a diet and exercise regimen. If blood sugar control is insufficient with monotherapy, it may be combined with insulin or other oral hypoglycemic agents. Additionally, when blood sugar control is difficult with sulfonylurea drugs or metformin monotherapy, using this medication alongside metformin is effective. Therefore, this medication helps improve blood sugar control in type 2 diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received drug therapy, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses greater than 4 mg, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the required dose of this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial Dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly during treatment with this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, monitor patients carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine and metformin are used in combination, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is coadministered with metformin, and the risk may increase. Appropriate caution is required.

Precautions

This medication should not be used in insulin-dependent diabetes patients or patients with severe liver or kidney dysfunction. It is also advisable to avoid administering it to pregnant or breastfeeding women. Patients who have had hypersensitivity reactions to sulfonylurea drugs should also avoid this medication. During the first week of taking the medication, the risk of hypoglycemia is high, so it is important to check blood sugar levels frequently. Elderly patients, those with poor nutritional status, irregular eating patterns, or impaired kidney or liver function require particular caution due to the high risk of hypoglycemia. Symptoms of hypoglycemia may include headache, severe hunger, dizziness, drowsiness, confusion, etc., and immediate intake of sugar is necessary upon experiencing these symptoms. Various side effects such as liver dysfunction, blood disorders, and allergic reactions may occur; thus, any abnormal symptoms should prompt immediate consultation with a doctor or pharmacist. For effective blood sugar control, it is important to combine this medication with diet and exercise. When taking other medications concurrently, it is essential to inform the healthcare provider about all medications being taken, as the effectiveness of this medication may be altered. In cases of overdose, severe hypoglycemia can occur, necessitating emergency treatment, and in severe cases, immediate hospital treatment may be required. This medication should be stored out of reach of children to ensure safety and should be kept in its original container to maintain quality.

Side effects

  • Hypoglycemia
  • headache
  • severe hunger
  • nausea
  • vomiting
  • fatigue
  • sleep
  • sleep disorder
  • anxiety
  • aggressiveness
Show 68 more
  • decreased concentration
  • reduced agility or motivation
  • depression
  • confusion
  • speech abnormalities
  • aphasia
  • visual impairment
  • tremors
  • incomplete paralysis
  • sensory abnormalities
  • dizziness
  • weakness
  • loss of self-control
  • temporary mental confusion
  • seizures
  • drowsiness
  • loss of consciousness
  • coma
  • shallow breathing
  • bradycardia
  • sweating
  • cold and clammy skin
  • tachycardia
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • blurred vision
  • fullness in the upper abdomen
  • pressure sensation
  • abdominal pain
  • diarrhea
  • increased liver enzymes
  • liver dysfunction
  • bile secretion disorders
  • jaundice
  • hepatitis
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • itching
  • hives
  • rash
  • respiratory distress
  • hypotension
  • shock
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • allergic vasculitis
  • photodermatitis
  • decreased serum sodium concentration
  • taste disorder
  • hair loss
  • weight gain
  • dizziness
  • liver dysfunction
  • abdominal pain
  • arthralgia
  • dyspepsia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's effectiveness and safety.

Appearance and packaging

Appearance

Green rectangular tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.